These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8832504)

  • 1. Elcatonin raises levels of vasoactive intestinal peptide in human plasma.
    Takeyama M; Ikawa K; Nagano T; Mori K
    J Pharm Pharmacol; 1996 Jun; 48(6):657-9. PubMed ID: 8832504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme immunoassay of elcatonin in human plasma.
    Takeyama M; Ikawa K; Eto I; Mori K
    Biol Pharm Bull; 1995 Jun; 18(6):900-2. PubMed ID: 7550129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme immunoassay for elcatonin, a synthetic analogue of eel calcitonin, in plasma.
    Aikawa R; Ohyama K; Mori E; Hironaka K; Miyake M; Morishita M
    J Pharm Sci; 1985 Mar; 74(3):300-3. PubMed ID: 2409265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
    Itoh H; Naito T; Takeyama M
    J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the bioavailability of intranasal elcatonin in humans: development of a sandwich transfer enzyme immunoassay for elcatonin.
    Kohno T; Murasugi N; Sakurai H; Watabe K; Nakamuta H; Koida M; Sugie Y; Ogouchi T; Inoue T; Yanaka M; Nomura M; Yanagawa A
    J Clin Lab Anal; 1998; 12(6):356-62. PubMed ID: 9850187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elcatonin-mediated contractile and relaxant responses in SHR femoral artery.
    Fujimoto S; Fujimoto SK
    Acta Pharmacol Sin; 2001 Jul; 22(7):595-602. PubMed ID: 11749822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of terfenadine on the plasma concentrations of substance P and vasoactive intestinal polypeptide in volunteers.
    Mori K; Asakura S; Morikawa N; Takeyama M
    J Pharm Pharmacol; 1992 Oct; 44(10):856-8. PubMed ID: 1280680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive action of elcatonin].
    Takayanagi N; Tozuka T; Toda N
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):383-93. PubMed ID: 6671629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of eel calcitonin derivative (elcatonin) in osteoporosis].
    Yoshikawa S; Shiba M; Hoshino T; Igarashi M; Orimo H; Sakuma A; Tsuyama N
    Nihon Seikeigeka Gakkai Zasshi; 1983 Nov; 57(11):1717-28. PubMed ID: 6676389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of a synthetic calcitonin derivative (elcatonin) in patients with metastatic bone tumors].
    Okayasu T; Masuda T; Hashimoto M; Tanabe T
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2703-9. PubMed ID: 3631970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: a multiclinic randomized controlled trial.
    Endo N; Fujino K; Doi T; Akai M; Hoshino Y; Nakano T; Iwaya T
    J Bone Miner Metab; 2017 Jul; 35(4):375-384. PubMed ID: 27465912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of incadronate and elcatonin in patients with malignancy-associated hypercalcaemia.
    Matsumoto T; Nagata N; Horikoshi N; Adachi I; Ohashi Y; Ogata E
    J Int Med Res; 2002; 30(3):230-43. PubMed ID: 12166339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of drug delivery systems for a therapeutic agent used in osteoporosis. I. Pharmacodynamics (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin.
    Watanabe Y; Mizufune Y; Kubomura A; Kiriyama M; Utoguchi N; Matsumoto M
    Biol Pharm Bull; 1998 Nov; 21(11):1187-90. PubMed ID: 9853410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2.
    Okubo Y; Bessho K; Fujimura K; Kusumoto K; Ogawa Y; Iizuka T
    Biochem Biophys Res Commun; 2000 Mar; 269(2):317-21. PubMed ID: 10708549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y; Chokki M; Ohta T; Kiyoki M
    Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea.
    Koch TR; Michener SR; Go VL
    Gastroenterology; 1991 Jan; 100(1):99-106. PubMed ID: 1983854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of plasma vasoactive intestinal peptide in human acute myocardial infarction.
    Gyöngyösi M; Németh J; Várkonyi T
    Int J Cardiol; 1996 Oct; 56(2):159-61. PubMed ID: 8894787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous absorption of elcatonin and hypocalcemic effect in rat.
    Ogiso T; Iwaki M; Yoneda I; Horinouchi M; Yamashita K
    Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):449-53. PubMed ID: 2054872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator Effects of Elcatonin, a Synthetic Eel Calcitonin, on Retinal Blood Vessels in Rats.
    Mori A; Suzawa H; Sakamoto K; Nakahara T; Ishii K
    Biol Pharm Bull; 2015; 38(10):1536-41. PubMed ID: 26424018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of synthetic eel calcitonin, elcatonin, in rats.
    Ogiso T; Funahashi N; Tsukioka Y; Iwaki M; Tanino T; Wada T
    Biol Pharm Bull; 2001 Jun; 24(6):656-61. PubMed ID: 11411554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.